Knowledge Center · Peptides

Sermorelin

GHRH analog

A growth hormone releasing hormone analog that prompts your pituitary to produce GH rather than replacing it.

Evidence strength: Limited evidence. Mechanism is characterized; human data is small or absent. It reliably raises GH and IGF-1 — that much is well established and was the basis of its diagnostic use. What is far less established is whether raising GH modestly in a healthy aging adult produces meaningful benefit in body composition, recovery, or quality of life. That question has been studied for decades without a satisfying answer, and the honest summary is that the mechanism is proven while the benefit is not.

What it is

Sermorelin is a shortened version of growth hormone releasing hormone, the signal your hypothalamus sends to the pituitary to release growth hormone. It was FDA-approved for pediatric growth hormone deficiency diagnosis and treatment before being withdrawn from the US market for commercial rather than safety reasons, and it remains widely available through compounding pharmacies.

What people use it for

  • Age-related decline in growth hormone output
  • Sleep quality, since the largest natural GH pulse occurs during deep sleep
  • Recovery and body composition support
  • As an alternative to exogenous growth hormone for people who prefer stimulating their own production

How it works

There are two ways to raise growth hormone: inject the hormone itself, or ask your pituitary to make more. Sermorelin does the second. The practical advantage is that your body's feedback loops stay intact — the pituitary releases GH in its natural pulsatile pattern and stops when signals say to stop, which is much harder to overshoot than direct injection.

The technical version

Sermorelin comprises the first 29 amino acids of GHRH, the portion carrying full biological activity. It binds pituitary GHRH receptors, stimulating synthesis and pulsatile release of endogenous growth hormone, which in turn raises hepatic IGF-1. Because release remains subject to somatostatin feedback, physiological pulsatility and the negative feedback ceiling are preserved. Plasma half-life is short — roughly 10 to 20 minutes — and it is typically administered at night to align with the natural nocturnal GH pulse.

What to realistically expect

Sleep quality changes, when they occur, are usually the first thing reported and appear within a few weeks. Body composition effects, if any, take months and are modest. Anyone expecting the effects associated with supraphysiologic growth hormone will be disappointed, which is arguably the point.

What it will not do

Every page on this site includes this section. If a source only tells you what something does, you are reading marketing.

  • It will not produce the dramatic effects of exogenous growth hormone, because the feedback loop it preserves specifically prevents that.
  • It will not work well in someone whose pituitary cannot respond — that is a different clinical problem.
  • It will not overcome poor sleep. Most of your GH is released during deep sleep, so fixing sleep is both the prerequisite and often the whole answer.
  • It will not build muscle without resistance training and adequate protein.

Safety and who should be cautious

The safety profile is generally regarded as favorable and better than exogenous growth hormone, precisely because it preserves feedback control. Injection site reactions and flushing are the common complaints. Not currently FDA-approved in the US, though available through compounding. Contraindicated in active malignancy given the IGF-1 relationship, and caution is warranted with diabetes since GH affects insulin sensitivity. Prohibited in sport. Not appropriate during pregnancy or breastfeeding.

Sourcing and quality

Compounding pharmacy product with a prescription is a genuinely different supply chain from research-grade material. If you qualify for the former, it is the better route.

Questions worth asking your provider

  • Should we measure IGF-1 before and after so we know whether anything actually changed?
  • Given my history, is raising IGF-1 appropriate for me?
  • Is my sleep actually optimized, since that is where most GH release happens?

Frequently asked questions

Is sermorelin safer than HGH?

It is generally considered so, because it preserves the feedback loop that prevents overshooting. That safety comes with a correspondingly smaller effect.

Is it FDA approved?

It was approved for pediatric use and later withdrawn from the US market for commercial reasons. It remains available through compounding pharmacies.

How does it compare to tesamorelin?

Both are GHRH analogs. Tesamorelin is longer-acting, currently FDA-approved for a specific indication, and considerably more expensive.

Have questions about your own situation?

General education only goes so far. If you want help deciding whether this is relevant to your goals, history, and current labs, schedule a consultation with the Bearing team.

Request a Consultation

Related

TesamorelinIpamorelinCjc 1295

Educational disclaimer. This page is for general education and is not medical advice. It does not diagnose, treat, or recommend any substance. Many peptides are not FDA-approved; legal status varies and some are prohibited in sport. Discuss any decision with a licensed provider.